Acetyl tetrapeptide-5
is used in cosmetic eye formulations to decrease puffiness, eye bags, and dark circles by reducing edema and protecting proteins such as SOD from glycation
Alanine
Ala / A · hydrophobic residue · neutral charge
AOD-9604
is studied as an anti-obesity peptide that can reduce weight gain and increase fat oxidation in obese animal models with generally neutral effects on IGF-1 and glucose metabolism in early human trials
Arginine
Arg / R · basic residue · positive charge
Argireline
is a topical cosmetic peptide reported to decrease dynamic wrinkles by partially mimicking the mechanism of botulinum toxin in a non-invasive manner
Asparagine
Asn / N · polar residue · neutral charge
Aspartic acid
Asp / D · acidic residue · negative charge
BPC-157
is investigated for accelerating healing of gastrointestinal mucosa, tendons, ligaments, bone, and nervous tissue in preclinical models, with anti-inflammatory and pro-angiogenic effects
Comparison
While Thymosin Alpha-1 is clinically used in some countries as an immunomodulator for chronic hepatitis B/C and as an adjuvant in cancer therapy, enhancing cell-mediated immunity41487, Tirzepatide is approved for type 2 diabetes and obesity, producing larger HbA1c and body-weight reductions than semaglutide in head-to-head trials24.
While Thymosin Alpha-1 works as a 28-amino-acid thymic peptide fragment of prothymosin alpha that activates dendritic cells and T cells primarily via TLR9/MyD88/NF-κB signaling, enhancing Th1 responses and NK-cell cytotoxicity414, Tirzepatide is a 39-amino-acid synthetic peptide primarily based on GIP sequence with C20 fatty diacid conjugation that acts as a dual agonist at GIP and GLP-1 receptors, enhancing glucose-dependent insulin secretion, suppressing glucagon, delaying gastric emptying, and reducing appetite24.
Thymosin Alpha-1
PTMA
Tirzepatide
Not assigned in the current dataset.
Thymosin Alpha-1 and Tirzepatide are noticeably different, with limited direct overlap in their usual biological context. Their typical research and application settings separate fairly clearly: Thymosin Alpha-1 is more often discussed in the realm of Immunology and inflammation and Oncology, whereas Tirzepatide is more often associated with the realm of Metabolic and endocrine and Cardiovascular health. They also influence different molecular systems, with Thymosin Alpha-1 tracking more closely to Toll-like receptor while Tirzepatide centers more on GLP-1 receptor. Thymosin Alpha-1 has a more natural endogenous origin, while Tirzepatide is closer to synthetic analog background. Thymosin Alpha-1 takes the form of a linear peptide, whereas Tirzepatide is closer to a peptide conjugate, Thymosin Alpha-1 carries acetylation features, while Tirzepatide instead reflects lipidation and d-amino acid substitution changes; while their sequence patterns also diverge, with Thymosin Alpha-1 showing protein-mimetic sequence features and Tirzepatide showing alpha-helical domain features.